Form 8-K - Current report:
SEC Accession No. 0001493152-25-015994
Filing Date
2025-09-29
Accepted
2025-09-29 16:05:39
Documents
12
Period of Report
2025-09-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 50869
  Complete submission text file 0001493152-25-015994.txt   216956

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sonn-20250926.xsd EX-101.SCH 3017
3 XBRL LABEL FILE sonn-20250926_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE sonn-20250926_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3710
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 251356065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)